Biomedical Engineering Reference
In-Depth Information
[61]
Ruland, J., Duncan, G.S., Wakeham, A.
et al., Differential requirement for MALT1
in T and B cell antigen receptor signaling,
Immunity,
19, 749, 2003.
[62]
Ruland, J., Duncan, G.S., Elia, A.
et al., Bcl10 is a positive regulator of antigen
receptor-induced activation of NF-kappaB and neural tube closure,
Cell,
104, 33, 2001.
[63]
Weil, R., Schwamborn, K., Alcover, A.
et al., Induction of the NF-kappaB cascade
by recruitment of the scaffold molecule NEMO to the T cell receptor,
Immunity,
18,
13, 2003.
[64]
Khoshnan, A., Bae, D., Tindell, C.A.
et al., The physical association of protein kinase
C theta with a lipid raft-associated inhibitor of kappaB factor kinase (IKK) complex
plays a role in the activation of the NF-kappaB cascade by TCR and CD28,
J.
Immunol.,
165, 6933, 2000.
[65]
Sun, Z., Arendt, C.W., Ellmeier, W.
et al., PKC-theta is required for TCR-induced
NF-kappaB activation in mature but not immature T lymphocytes,
Nature,
404, 402,
2000.
[66]
Lee, K.Y., D'Acquisto, F., Hayden, M.S. et al., PDK1 nucleates T cell receptor-
induced signaling complex for NF-kappaB activation,
Science,
308, 114, 2005.
[67]
Egawa, T., Albrecht, B., Favier, B.
et al., Requirement for CARMA1 in antigen
receptor-induced NF-kappaB activation and lymphocyte proliferation,
Curr. Biol.,
13,
1252, 2003.
[68]
Gaide, O., Favier, B., Legler, D.F.
et al., CARMA1 is a critical lipid raft-associated
regulator of TCR-induced NF-kappaB activation,
Nat. Immunol.,
3, 836, 2002.
[69]
Bertin, J., Wang, L., Guo, Y.
et al., CARD11 and CARD14 are novel caspase recruit-
ment domain (CARD)/membrane-associated guanylate kinase (MAGUK) family
members that interact with BCL10 and activate NF-kappaB,
J. Biol. Chem.,
276,
11877, 2001.
[70]
Gaide, O., Martinon, F., Micheau, O.
et al., Carma1, a CARD-containing binding
partner of Bcl10, induces Bcl10 phosphorylation and NF-kappaB activation,
FEBS
Lett.,
496, 121, 2001.
[71]
Ruefli-Brasse, A.A., Lee, W.P., Hurst, S.
et al., Rip2 participates in Bcl10 signaling
and T-cell receptor-mediated NF-kappaB activation,
J. Biol. Chem.,
279, 1570, 2004.
[72]
Zhou, H., Wertz, I., O'Rourke, K. et al., Bcl10 activates the NF-kappaB pathway
through ubiquitination of NEMO,
Nature,
427, 167, 2004.
[73]
Sun, L., Deng, L., Ea, C.K.
et al., The TRAF6 ubiquitin ligase and TAK1 kinase
mediate IKK activation by BCL10 and MALT1 in T lymphocytes,
Mol. Cell,
14, 289,
2004.
[74]
Su, T.T., Guo, B., Kawakami, Y.
et al., PKC-beta controls I kappa B kinase lipid raft
recruitment and activation in response to BCR signaling,
Nat. Immunol.,
3, 780, 2002.
[75]
Ivanov, V.N. and Nikolic-Zugic, J., Transcription factor activation during signal-
induced apoptosis of immature CD4(+)CD8(+) thymocytes: A protective role of
c-Fos,
J. Biol. Chem.,
272, 8558, 1997.
[76]
Jeremias, I., Kupatt, C., Baumann, B.
et al., Inhibition of nuclear factor kappaB
activation attenuates apoptosis resistance in lymphoid cells,
Blood,
91, 4624, 1998.
[77]
Wan, Y.Y. and DeGregori, J., The survival of antigen-stimulated T cells requires
NFkappaB-mediated inhibition of p73 expression,
Immunity,
18, 331, 2003.
[78]
Kontgen, F., Grumont, R.J., Strasser, A.
et al., Mice lacking the c-rel proto-oncogene
exhibit defects in lymphocyte proliferation, humoral immunity, and interleukin-2
expression,
Genes Dev.,
9, 1965, 1995.
[79]
Ghosh, P., Tan, T.H., Rice, N.R.
et al., The interleukin 2 CD28-responsive complex
contains at least three members of the NF-kappaB family: c-Rel, p50, and p65,
Proc.
Natl. Acad. Sci. USA,
90, 1696, 1993.
